Molecular Remedies Private Limited - Company Profile

It is a chemicals private limited company based in Roorkee, Uttarakhand, India, established in 2013.
2013 Roorkee, Uttarakhand, India Struck Off
Last Updated:
Access Report
About Molecular Remedies Private Limited

Molecular Remedies Private Limited, a struck off private limited company, was established on 25 November 2013 in Roorkee, Uttarakhand, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100UR2013PTC000937. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shahtaj Parvez (Director), Asif Malik (Director). It is based at 299, Shekh Puri, Roorkee, Uttarakhand, 247667.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100UR2013PTC000937

  • Registration Number

    000937

  • Incorporation Date

    25 November 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Uttarakhand

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 3 Months
Company report

Molecular Remedies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Molecular Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Molecular Remedies Private Limited?
Current Directors
Name Designation Appointment Date Status
Shahtaj Parvez Director 25 Nov 2013 Current
Asif Malik Director 25 Nov 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Molecular Remedies.

Enhance accessibility to Molecular Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Molecular Remedies revenue growth over time
Molecular Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Molecular Remedies?

Unlock access to Molecular Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Molecular Remedies?

Unlock and access historical data on people associated with Molecular Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Molecular Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Molecular Remedies
Recent Activity within the Organization
  • Director Appointment

    The activity Shahtaj Parvez was appointed as a Director was appointed as a Director on 25 Nov 2013 & has been associated with this company since 12 years 3 months . was completed.

  • Director Appointment

    Asif Malik was appointed as a Director was appointed as a Director on 25 Nov 2013 & has been associated with this company since 12 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Molecular Remedies Private Limited was registered on 25 Nov 2013 with Roc Uttarakhand & aged 12 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Molecular Remedies Private Limited?

The CIN of Molecular Remedies Private Limited is U24100UR2013PTC000937.

Where is Molecular Remedies Private Limited headquartered?

Molecular Remedies Private Limited is headquartered at 299, Shekh Puri, Roorkee, Uttarakhand, 247667.

When was Molecular Remedies Private Limited incorporated?

Molecular Remedies Private Limited was incorporated on 25 November 2013.

Who are the current directors of Molecular Remedies Private Limited?

The current directors of Molecular Remedies Private Limited are

What is the primary industry of Molecular Remedies Private Limited?

The primary industry of Molecular Remedies Private Limited is Chemicals.

Is Molecular Remedies Private Limited a listed company?

Molecular Remedies Private Limited is unlisted.

What is the capital structure of Molecular Remedies Private Limited?

The authorized capital of Molecular Remedies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available